Supplementary Figure 5 from Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: All ADCC ratios from Figure 3 and trastuzumab/pertuzumab ADCC comparison
Authors: Denis M. Collins, Stephen F. Madden, Nicola Gaynor, Dalal AlSultan, Marion Le Gal, Alex J. Eustace, Kathy A. Gately, Clare Hughes, Anthony M. Davies, Thamir Mahgoub, Jo Ballot, Sinead Toomey, Darran P. O'Connor, William M. Gallagher, Frankie A. Holmes, Virginia Espina, Lance Liotta, Bryan T. Hennessy, Kenneth J. O'Byrne, Max Hasmann, Birgit Bossenmaier, Norma O'Donovan, John Crown
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361889753